Literature DB >> 22867868

HPV16 activates the promoter of Oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation.

Dongbo Liu1, Peng Zhou, Li Zhang, Yingru Zheng, Fengtian He.   

Abstract

Human papillomavirus 16 (HPV16) is the key factor to initiate cervical carcinogenesis and development. Octamer-binding transcription factor 4 (Oct4) is an important transcriptional factor which is up-regulated in some cancer cells. Our study showed that the expression of Oct4 might be activated by HPV16 infection. Both the levels of histone deacetylase 1 (HDAC1) and DNA methyltransferase 3A (DNMT3A) were negatively correlated with the level of Oct4 in cervical cancer cells. Moreover, HDAC1 and DNMT3A proteins were in the same complex, the level of which was higher in the presence of HPV16. The treatment with HDAC1 inhibitor reduced the level of this complex, followed by the upregulation of Oct4 expression. Based on these findings and previous reports, we hypothesize that a repressor complex containing methyl CpG-binding domain protein 2 (MBD2), DNMT3A and HDAC1 binds to the hyper-methylated regulatory regions of Oct4 gene to facilitate forming a close chromatin which results in the suppression of Oct4 transcription in cervical cells. The oncoproteins of HPV16 synergistically sequester HDAC1 protein from repressor complex, and target it to ubiquitin mediated proteasome degradation. The repressor complex is thus destroyed and the close chromatin is relaxed, which eventually lead to the upregulation of Oct4 expression.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867868     DOI: 10.1016/j.mehy.2012.07.012

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.

Authors:  Xiangya Ding; Jingyun Xu; Cong Wang; Qi Feng; Qingxia Wang; Yue Yang; Hongmei Lu; Fei Wang; Kaixiang Zhu; Wan Li; Qin Yan; Shou-Jiang Gao; Chun Lu
Journal:  Cell Death Differ       Date:  2019-01-22       Impact factor: 15.828

2.  Molecular, biological characterization and drug sensitivity of chidamide-resistant non-small cell lung cancer cells.

Authors:  Song'e Luo; Kai Ma; Hongxia Zhu; Shuren Wang; Mei Liu; Weina Zhang; Shufang Liang; Ningzhi Xu
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

3.  Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.

Authors:  Zi-Ye Gao; Xiao-Bo Liu; Feng-Mei Yang; Ling Liu; Jin-Zhang Zhao; Bo Gao; Sheng-Bao Li
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

4.  HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.

Authors:  Shujuan Shu; Zhi Li; Liu Liu; Xia Ying; Yina Zhang; Ting Wang; Xiaoye Zhou; Peiyue Jiang; Weiguo Lv
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

5.  Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.

Authors:  Wuniqiemu Tulake; Reziwanguli Yuemaier; Lei Sheng; Mingfang Ru; Dilare Lidifu; Abulizi Abudula
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.